Cognitive impairment in Parkinson's disease
D Verbaan1, J Marinus, M Visser
1Department of Neurology, K5Q-92, Leiden University Medical Centre, PO Box 9600, NL- 2300 RC Leiden, The Netherlands. D.Verbaan@lumc.nl
Journal of Neurology, Neurosurgery, and Psychiatry
|April 20, 2007
Summary
Cognitive impairment is common in Parkinson's disease (PD), affecting executive function and memory. Poorer cognitive performance in PD patients correlates with motor and non-motor symptom severity, especially in the postural instability gait difficulty phenotype.
Area of Science:
- Neurology
- Neuroscience
- Cognitive Science
Background:
- Cognitive impairment is a significant, yet not fully understood, aspect of Parkinson's disease (PD).
- Previous studies faced limitations due to inconsistent and unreliable measurement tools for cognitive assessment in PD.
- This study utilized the validated SCales for Outcomes in PArkinson's disease-COGnition (SCOPA-COG) instrument for accurate measurement.
Purpose of the Study:
- To comprehensively evaluate cognitive functioning in a large cohort of Parkinson's disease patients.
- To investigate the relationships between cognitive performance and demographic, disease-related, and clinical variables in PD.
- To compare cognitive function in PD patients against a matched control group.
Main Methods:
- A cohort of 400 Parkinson's disease patients underwent assessment of cognition, motor, and non-motor domains.
- Demographic and disease-related characteristics were collected for all participants.
- Results were compared to 150 age, sex, and education-matched healthy controls.
Main Results:
- Parkinson's disease patients demonstrated significantly lower scores across all cognitive subdomains compared to controls, particularly in executive functioning and memory.
- After adjusting for age and education, 22% of PD patients exhibited cognitive impairment as per the SCOPA-COG total score.
- Greater cognitive impairment in PD was significantly associated with increased severity in motor, autonomic, depressive, and psychotic domains.
- The postural instability gait difficulty (PIGD) dominant phenotype showed more pronounced cognitive impairment than the tremor-dominant phenotype.
- PIGD scores worsened significantly with increasing disease severity, unlike tremor scores.
Conclusions:
- Cognition is a critical component of the Parkinson's disease clinical spectrum.
- Poorer cognitive performance in PD is strongly linked to greater impairment across both motor and non-motor domains.
- The observed cognitive differences between PIGD-dominant and tremor-dominant phenotypes suggest more advanced disease in the former.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...